Nano pharmaceuticals market analysis| Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation

Nano pharmaceuticals market analysis| Coherent Market Insights


Read here the latest updates on the Nano pharmaceuticals market analysis published by the CMI team. – PowerPoint PPT presentation

Number of Views:5
Date added: 7 September 2020
Slides: 13
Provided by: adwaitcoherent


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Nano pharmaceuticals market analysis| Coherent Market Insights

Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//
  • Covid-19 Impact Tracker

  • Nanopharmaceuticals Market, by Carrier Type
    (Liposomes, Polymer, Nanocrystals, Inorganic,
    Protein, and Others), by Application (Oncology,
    Neurology, Anti-inflammatory, Anti-infective,
    Cardiovascular, and Others), by End User
    (Hospital Pharmacies, Retail Pharmacies, and
    Online Pharmacies), and by Region (North America,
    Latin America, Europe, Asia Pacific, Middle East,
    and Africa) - Global industry Insights and
    Forecast till 2026
  • Nanopharmaceuticals are novel medicine with
    particle size less than 1 micron, which work on
    the principle of nanotechnology.
    Nanopharmaceuticals are widely used in drug
    delivery as a carrier for therapeutic compound or
    as a therapeutic compound. Nanopharmaceuticals
    are designed to target particular cells, tissue
    or a specific organ.

  • Market Dynamics
  • Increasing prevalence of cardiovascular diseases,
    cancer, and infectious diseases are major factors
    driving nanopharmaceuticals market growth. The
    World Health Organization, factsheet September
    2018, estimated around 10 million cases of
    tuberculosis and around 1.6 million deaths from
    the disease in 2017. Moreover, advantages of
    nanopharmaceuticals over macroscopic level
    medicines is expected to boost the market growth.
    Nanopharmaceuticals can pass the blood brain
    barrier and can access the remote areas of brain
    as well as low solubility of the compound can be
    developed for enhancing its characteristics.

  • Key features of the study
  • This report provides in-depth analysis of the
    nanopharmaceuticals market and provides market
    size (US million) and Compound Annual Growth
    Rate (CAGR ) for the forecast period (2018
    2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities
    across different segments and explains attractive
    investment proposition matrices for this market
  • This study also provides key insights about
    market drivers, restraints, opportunities, new
    product launches or approval, market trends,
    regional outlook, and competitive strategy
    adopted by key players
  • It profiles key players in the global
    nanopharmaceuticals market based on the following
    parameters company overview, financial
    performance, product portfolio, market presence,
    distribution strategies, key developments,
    strategies, and future plans
  • Key companies covered as a part of this study
    include, Abbott, GlaxoSmithKline and plc., Eli
    Lilly and Company, Astrazeneca plc., Novavax,
    Inc., Stryker Corporation, OSI Pharmaceuticals,
    Kadmon Pharmaceuticals, Samyang Biopharm,
    Mitsubishi Tanabe Pharma Corporation, Kaken
    Pharmaceutical, Selecta Biosciences, Par
    Pharmaceutical, Cerulean Pharma Inc., Navidea
    Biopharmaceuticals, Inc., AbbVie Inc., AMAG
    Pharmaceuticals, Amgen Inc., Astellas Pharma
    Inc., Celgene Corporation, Gilead Sciences, Inc.,
    JOHNSON JOHNSON, Merck Co., Inc., Novartis
    AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi
    S.A, Shire Plc., and Teva Pharmaceuticals
    Industries Limited.

  • Detailed Segmentation
  • Global Nanopharmaceuticals Market, By Carrier
  • Liposomes
  • Polymer
  • Nanocrystals
  • Inorganic
  • Protein
  • Others
  • Global Nanopharmaceuticals Market, By
  • Oncology
  • Neurology
  • Anti-inflammatory
  • Anti-infective
  • Cardiovascular
  • Others

Figure 1. Global Nanopharmaceuticals Market Value
(US Mn), by Region, 2017

Figure 2. Global Nanopharmaceuticals Market Share
(), by Carrier Type, 2018 and 2026
Rising prevalence of chronic diseases in North
America is expected to drive the North America
nanopharmaceuticals market growth
  • North America holds dominant position in the
    global nanopharmaceuticals market, owing to
    increasing research and development activities in
    application of nanotechnology in pharmaceuticals
    and rising prevalence of chronic disorders.
    According to the Centers for Disease Control and
    Prevention (CDC) factsheet, around 6 in 10 adults
    are diagnosed with chronic diseases and 4 in 10
    adults have two chronic diseases in the U.S.
    According to the same source, chronic diseases
    account for around 75 of healthcare spending in
    the U.S.
  • Key manufacturers in the region focuses on
    developing and innovating new drugs for meeting
    the needs of patients, which is expected to
    bolster the market growth over the forecast
    period. For instance, in October 2012, Celgene
    Corporation, a U.S.-based company, received
    approval from the U.S. Food and Drug
    Administration (FDA) for Abraxane (paclitaxel
    protein-bound particles for injectable
    suspension), which is used for first-line
    treatment of advanced non-small cell lung cancer.
  • Moreover, key players in the market are focused
    on receiving the U.S. Food and Drug
    Administration (FDA) approval for novel products
    to treat patients. For instance, in May 2017,
    NovoNodisk received Food and Drug Administration
    (FDA) approval for glycopegylated Rebinyn, which
    is used to control bleeding and bleeding
    management in patients diagnosed with hemophilia

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email

Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//